Making MD before 30

Is it true that all young MD's in Investment Banks are from the trading division since they can show objective P&L stats?


During my BNP Paribas SA internship there was a trader who had just made MD at 28; seems impossible in IBD. Am I wrong for thinking this? 

 

I’m in Europe IB so generally people start as analysts older than in the US, but I have never ever seen an IB MD that is under 30. Since industry knowledge, track record and especially network is crucial in order to bring in deals and revenue, it would be very rare to have a sub-30 year old with those skills, trustability and network (for a BB/EB).

More probable for like a tech boutique advising startups or younger companies with younger founders/mgmt.

 

You are correct, at a BB making MD before 30 is possible in S&T and virutally impossible in IBD

Most markets programs require 2 years at each position, so you can in theory (and it happens in practice) make MD at 30. 

Also another thing to note is that comp is not as restrictive in S&T relative to IBD, so you could on paper be an associate but be comped like a Director. For example, when Hamza Lemssougguer was an associate at CS he had MDs reporting directly to him, and I refuse to believe he was being paid less than them.

 

Was at a top MM bank and someone made MD right around 30 - minimum there was 2 analyst + 3 associate, but you could theoretically do 2 years as VP and one as director which would be 8 years to MD which would mean 29-30ish.

The issue is you need to prove you can bring in business to make MD, and it would be very challenging to be a 28 year old director and have the respect needed to win engagements. So theoretically possible but just highly unlikely, even for a top performer

 

I worked with a guy who made it at 31/32 at an MM - he was very smart and thought he should’ve gotten the nod at 30 but was told he needed more grey hair and senior execution reps.

 

Most of the MDs I know who made it by 30, which were not alot, were in trading and directly contributed to a PnL.

That being said, I know a handful of kids who made around 33 in investment banking.

It’s like anything in life, you need a mix of hard work, mentorship and a little luck (like a few seniors above you leave and you step up to fill that gap).

 
Most Helpful

In the US, generally a person graduates at age 22 in June and prob start in a BB or equivalent FI corp in the following few months (Aug or Sept). Starting off they must be analyst for at least 2 yrs minimum sometimes 3 depending on the FI. 22+3 = 25 yrs old. If you make it to be Associate that's another 2 - 3 yrs as an associate. 25+2 = 27 yrs old. If they perform well enough to be VP next then that's where they kind of stay static a bit or unless he/she is an extremely good performance to get recognized, usually falls within 5yr +/- range. 27+5 = 32 yrs age at minimum if just standard corporate ladder route without acceleration. So it's very unlikely/rare occurance to make it to MD before 30. From 32 end of VP, your next route is to be Dir, which that is indefinite can be 10+ yrs before even thinking about being MD. Of course this is all just based off what I been seeing over the years in the field. Haven't seen or met anyone that moved/jumped ship which accelerated into MD before 30. Not saying it's impossible; just haven't seen it (yet) in my career life time.

 

In practice it’s certainly possible to make MD by 30.

That being said, I’ve noticed that “title inflation” has become fairly aggressive over the past few years (probably for retention, diversity and marketing/pitching purposes). I personally don’t think the MD title carries the same weight as it did 10+ years ago.

 

Whats the point? You end up hitting a glass ceiling very early in your career and become a shooting duck when things go south i.e poor pnl on a particular year. (Banks tend to be more forgiving and lenient towards juniors when it comes to firing, especially in Global Markets) Of course, there are truly exceptional good star traders that deserves this early promotion as they can provide consistent strong pnl, even during bad years. But can you?

 

This is the truth. Everyone focused on doing the year per level math and saying it’s possible which really isn’t relevant.

In reality moving up too fast can stunt your growth and then you’re a walking deadman at 30 because you’re expensive and no one is going to hire you as you most likely don’t have the judgement, connections, and experiences to lead a company through a transaction event.

 

Its unfortunate that things are stuck this way. Age and experience are not necessarily a sign of wisdom and competence. A young MD can be much more competent than a 50 year old MD, and vise versa. 

 

This isn’t trading. Younger bankers likely haven’t had time to develop relationships with CEOs and corporate development teams to know who is buying your client, how much they are paying, when is the right time, and how to position it.

These typically aren’t things you can understand without going through several deals and having the experience of failed deals

As an analyst, it is hard to do your work and call a bunch of corp dev people to get to know them.

 

Very difficult. Usually takes 10+ years at a BB. It's especially difficult in Europe where a lot of people do master's and take gap years before their bachelor's and between bachelor's and master's. Very very common to see people that are ~25 years old when they start as an analyst in Europe. As such, best case scenario many Europeans make MD at 35-40. 

 

Macron became an md at 31, right?

obv, special scenario lol

 

Thank you for the info. This confirms what I was thinking, young MD's only really exist in S&T because there are no fix programs in S&T, you rise if you are good and if not you can stay at VP level for 15 years or get fired very easily. 

I would say IBD has a higher level of job security whilst S&T division has much lower job security (most get fired at leats once or twice in their careers) but it is a meritocracy in the sense that if you are good you will rise, whilst IBD MD path is mostly about connections only (still relevant in S&T of course).

 

Iusto architecto et laudantium. Iusto possimus accusantium delectus enim. Officia provident exercitationem sed aliquid et aspernatur. Voluptas ea animi blanditiis dolore. Quis odio et voluptate amet id.

Consequatur omnis beatae rerum excepturi. Quasi tempore et consequatur optio. Similique et dolorem velit autem possimus iusto.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
CompBanker's picture
CompBanker
98.9
8
kanon's picture
kanon
98.9
9
bolo up's picture
bolo up
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”